Subcutaneous administration of IFN-β resulted in a complete regression of MCPyV-positive MCC tumors in a Japanese patient, but IFN-α-2b treatment of an 84-year-old man and an 81-year-old woman had no effect [203,204]. The gene discussed is IFNB1; the disease is Merkel cell skin cancer.